News In Research

The MND Association's activities and contacts helps us to keep up to date with the latest research news. Below are some articles that have recently hit the headlines.

Stem cell safety trials get underway

The U.S. Food and Drugs Administration has given the go-ahead for stem cell treatments for MND to enter the earliest stage of the clinical trials process.


My symposium

Read the latest news from the 20th International Symposium on ALS/MND. Read our highlights and insights in our blog as well as resesarchers reflections and pictures from this year's conference.


Gene variation leads to earlier age of onset

A Canadian-led research group has identified a genetic 'spelling variation' that appears to reduce the age at which somebody develops MND.


Places available on drug trial

People with MND are being recruited for an important clinical trial of the drug lithium carbonate, taking place at ten centres around England. This trial, funded by the MND Association, will provide neurologists with vital evidence about this potential treatment.


Genetic Risk Factors Found in Sporadic MND

An international genome wide association study, led by Prof Van den Berg and including MND Association funded researchers, has identified three genetic variations (subtle differences in 'spelling' of the genetic code) that increase the risk of somebody developing MND.


Research news archive

Look back over the news from the past couple of years.